A PYMNTS Company

Israel: Shufersal must sell 9 Pharm branches to complete merger

By  |  September 7, 2017

The Israel Antitrust Authority mergers committee is scheduled to convene on Wednesday, September 7, to set the final conditions for closing and carrying out the merger between leading supermarket chain Shufersal and New Pharm Drugstores.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    A single buyer must acquire all nine branches and maintain them as a pharmacy chain, the Israel Antitrust Authority decrees.

    Shufersal will have to sell 10 branches: nine branches of the New Pharm chain and one Shufersal branch with a problematic location. The branches must be sold as a single division, i.e. to one buyer, and maintained as a pharmacy chain in order to provide a platform for two competing chains —Shufersal and Super-Pharm— in addition to good infrastructure for the growth of a third chain.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.